CBD and gabapentin: low pharmacokinetic risk, real sedation concern

Why gabapentin is different from most drug interactions

Gabapentin is unusual among common prescription medications: it is absorbed in the small intestine via a saturable transporter (LAT1/2), is not protein-bound, and is eliminated unchanged by renal excretion with no hepatic metabolism. There are no CYP enzymes involved.

This means the core CBD drug-interaction mechanism — CYP enzyme inhibition raising drug plasma levels — doesn't apply to gabapentin. See the CYP450 explainer for the contrast with CYP-mediated interactions like warfarin or statins.

The additive sedation concern

What does apply is a pharmacodynamic interaction: gabapentin causes CNS depression and sedation, particularly at higher doses and in older adults. CBD also has sedative properties at higher doses (the Shannon 2019 sleep signal is partly about CBD's sedative-anxiolytic effect at bedtime doses). When both are present, the sedation can add.

This is the same logic as the benzodiazepine additive sedation concern — not a pharmacokinetic mechanism, but a drug-effect one. For someone who already experiences some drowsiness from gabapentin, adding CBD may intensify that effect.

The kidney function nuance

Gabapentin dosing is adjusted for renal function (prescribers reduce dose as eGFR falls). CBD is not significantly renally cleared — it's hepatically metabolized — so CBD doesn't directly compete with gabapentin's elimination pathway. However, for anyone with meaningful kidney impairment, adding any new substance should be a prescriber conversation, as the interplay of impaired elimination and sedative effects has greater clinical consequences.

What this means for you

1. Tell your prescriber. Even though the pharmacokinetic risk is low, additive sedation is real and your prescriber should know you're combining CBD with gabapentin — especially if you drive, operate machinery, or are at fall risk.
2. Start CBD at a low dose. If you're new to CBD, start at 10–15mg (see the titration protocol) and assess sedation before increasing.
3. Time of day matters. If gabapentin already causes daytime drowsiness, taking CBD at bedtime rather than during the day can separate the sedative peaks and reduce daytime impairment.
4. Older adults should be especially cautious. Gabapentin's sedation and fall risk is well-documented in the elderly. Additive CBD sedation warrants a frank conversation with your prescriber if you're over 65.
5. The topical is sedation-neutral. The NANO roll-on for local joint or muscle use doesn't have the systemic sedative exposure of oral CBD — a useful option if sedation is the primary concern.